David Micinski
Minerva Foundation Institute for Medical Research
3 Papers
17 Citations
David Micinski is an academic researcher from Minerva Foundation Institute for Medical Research. The author has contributed to research in topics: Axon initial segment & Actin cytoskeleton. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Tropomyosin Tpm3.1 Is Required to Maintain the Structure and Function of the Axon Initial Segment
Amr Abouelezz,Amr Abouelezz,Holly Stefen,Mikael Segerstråle,David Micinski,Rimante Minkeviciene,Lauri Lahti,Edna C. Hardeman,Peter W. Gunning,Casper C. Hoogenraad,Tomi Taira,Thomas Fath,Thomas Fath,Pirta Hotulainen +13 more
TL;DR: Results show that Tpm3.1 is necessary for the structural and functional maintenance of the AIS and led to reduced accumulation of AIS structural andfunctional proteins, disruption in sorting somatodendritic and axonal proteins, and a reduction in firing frequency.
25
Tropomyosin Tpm3.1 is required to maintain the structure and function of the axon initial segment
Amr Abouelezz,Amr Abouelezz,Holly Stefen,Mikael Segerstråle,David Micinski,Rimante Minkeviciene,Edna C. Hardeman,Peter W. Gunning,Casper C. Hoogenraad,Tomi Taira,Thomas Fath,Pirta Hotulainen +11 more
TL;DR: This study found that the tropomyosin isoform Tpm3.1 decorates a population of relatively stable actin filaments in the AIS which provides a scaffold for membrane organization and AIS proteins.
19
Sub-membranous actin rings in the axon initial segment are resistant to the action of latrunculin.
TL;DR: Both latrunculin A and B markedly reduced the overall amount of F-actin in treated neurons in a dose-dependent manner, but the periodicity of actin rings remained unaffected, suggesting the insensitivity of AIS actin Rings to lat runculin suggests they are relatively stable.